machine learning
Genialis, Debiopharm Extend Cancer Biomarker Collaboration
The companies extended a deal to develop biomarkers predictive of the clinical benefit of Debiopharm's cancer drug candidates.
The model uses clinical and genomic features to predict whether patients will respond to first-line CDK4/6 and endocrine therapy.
A half-dozen hospital systems plan to implement the tool, which combs through patient medical records to identify those suspected to have high Lp(a).
Caris Life Sciences, ECOG-ACRIN to Analyze Breast Tumor Samples From Landmark TAILORx Study
Through a new partnership, Caris will use its comprehensive genomic profiling tests to sequence more than 10,000 early-stage breast tumors collected in TAILORx.
Avacta Therapeutics, Tempus Partner to Advance FAP-Based Peptide Drug Conjugates
Avacta will tap into Tempus' real-world data and machine-learning abilities to develop drugs with its fibroblast activation protein (FAP)-based platform.